The U.S. Food and Drug Administration (FDA) has approved TIBSOVO (ivosidenib) for the treatment of relapsed or refractory adult acute myeloid leukemia···【Read More】
Update: 2026-03-25Source: Haiou HealthViews: 89
In 2021, Agios presented a comprehensive analysis of final data from the global Phase 3 ClarIDHy trial of the targeted anticancer drug ivosidenib (TIB···【Read More】
Update: 2026-03-25Source: Haiou HealthViews: 89
On May 25, 2022, Servier announced that the U.S. FDA had approved ivosidenib (Tibsovo) in combination with azacitidine for the treatment of newly diag···【Read More】
Update: 2026-03-25Source: Haiou HealthViews: 89
According to a press release from Servier Pharmaceuticals on October 24, the US Food and Drug Administration (FDA) announced that its IDH1 inhibitor T···【Read More】
Update: 2026-03-25Source: Haiou HealthViews: 87
According to a press release from Servier Pharmaceuticals, the U.S. Food and Drug Administration (FDA) has accepted and granted priority review to the···【Read More】
Update: 2026-03-25Source: Haiou HealthViews: 86
Certain medications may interact with enasidenib, including prescription drugs, over-the-counter medications, vitamins, and herbal supplements. Inform···【Read More】
Update: 2026-03-25Source: Haiou HealthViews: 93
Follow your physician’s guidance regarding any restrictions on food, beverages, or physical activity.【Read More】
Update: 2026-03-25Source: Haiou HealthViews: 97
Seek immediate emergency medical care or contact the Poison Control Center hotline.【Read More】
Update: 2026-03-25Source: Haiou HealthViews: 94
Take the missed dose as soon as you remember it on the same day. Resume your once-daily dosing schedule by taking your next dose at your usual time. D···【Read More】
Update: 2026-03-25Source: Haiou HealthViews: 94
The price of Enxidipine (used for certain acute myeloid leukemias) varies significantly depending on the version, specification, and distribution chan···【Read More】
Update: 2026-03-25Source: Haiou HealthViews: 93
Enasidenib is a prescription drug used to treat certain types of leukemia. Its price varies depending on the dosage, region, and purchase channel, typ···【Read More】
Update: 2026-03-25Source: Haiou HealthViews: 88
Enasidenib dosage and administration must strictly follow the doctor's instructions and be administered under the guidance of a professional physi···【Read More】
Update: 2026-03-24Source: Haiou HealthViews: 97
Idhifa (Ensidipin), an oral formulation jointly developed by Celgene and Agios Pharmaceuticals, is indicated for adult patients with relapsed or refra···【Read More】
Update: 2026-03-24Source: Haiou HealthViews: 95
On August 1, 2017, the U.S. Food and Drug Administration (FDA) officially approved IDHIFA (enasidenib) for the treatment of adult patients with relaps···【Read More】
Update: 2026-03-24Source: Haiou HealthViews: 94
Certain medications should not be used together, as this can compromise safety. Some drugs can alter the blood concentrations of entrectinib, which ma···【Read More】
Update: 2026-03-24Source: Haiou HealthViews: 90
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos



